Dianthus Therapeutics, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:DNTH) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 374.01 M348.58 M326.08 M577.45 M530.92 M1.25 B 負債合計 21.53 M19.97 M23 M30.99 M37.52 M45.57 M 純資産合計 352.48 M328.61 M303.08 M546.45 M493.4 M1.2 B 負債および純資産合計 374.01 M348.58 M326.08 M577.45 M530.92 M1.25 B 有利子負債合計 —————— 純負債 ——————

ニュース

Dianthus Therapeutics: A Financed Autoimmune Platform With More Than One Way To Win (NASDAQ:DNTH)

Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Lags Revenue Estimates

Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?

William Blair、CIDP試験データを受けDianthus株の投資判断を維持

William Blair reiterates Dianthus stock rating on CIDP trial data

Dianthus Therapeutics CEO Garcia氏が1000万ドル相当の株式を売却

Dianthus TherapeuticsのEVP Randhawa氏が276万ドル相当の株式を売却

Dianthus Therapeuticsの最高会計責任者が356万ドル相当の株式を売却

Dianthus Therapeuticsが7億1900万ドルの公募増資を完了

Dianthus Therapeutics closes $719M public offering

Dianthus、1株81ドルで6億2500万ドルの株式公募を実施

Dianthus prices $625M stock offering at $81 per share